A Phase I Single Center, Double-Blind, Placebo-Controlled, Multiple Dose-Ascending Study to Evaluate the Pharmacokinetics and Tolerability of CTP-730 Immediate Release at Steady State in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs CTP 730 (Primary)
- Indications Cancer; Inflammation
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Concert Pharmaceuticals
- 30 Jun 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 28 May 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.
- 31 Mar 2015 Status changed from planning to recruiting as reported by ClinicalTrials.gov record.